(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.
| Image |  |
|---|---|
| Description | scientific article published on 25 February 2015 |
| Author/s |
author: Michel Chérel Joelle Gaschet Norbert Ifrah |
| Publication date | February 25, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |